TransMedics Group, Inc. TMDX Product — Cost Of Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by TransMedics Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about TransMedics Group, Inc.'s product — cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TransMedics Group, Inc.'s product — cost of revenue?
- TransMedics Group, Inc. (TMDX) reported product — cost of revenue of $24.31M in Q1 2026.
- How has TransMedics Group, Inc.'s product — cost of revenue changed year-over-year?
- TransMedics Group, Inc.'s product — cost of revenue increased by 49.0% year-over-year, from $16.31M to $24.31M.
- What is the long-term trend for TransMedics Group, Inc.'s product — cost of revenue?
- Over 4 years (2021 to 2025), TransMedics Group, Inc.'s product — cost of revenue has grown at a 71.3% compound annual growth rate (CAGR), from $9.03M to $77.82M.
- What does product — cost of revenue mean?
- This metric captures the direct costs incurred to manufacture, procure, and deliver the physical products sold by the business segment. It includes expenses such as raw materials, direct labor, and manufacturing overhead directly attributable to product sales. Monitoring this metric is essential for evaluating the production efficiency and gross margin potential of the company's hardware or technology portfolio.